Breast cancer screening in transgender patients: findings from the 2014 BRFSS survey
Breast cancer screening in transgender patients: findings from the 2014 BRFSS survey
复制标题
DOI：
10.1007/s10549-017-4461-8
复制
发表时间：
2017-12-01
影响因子：
3.8
通讯作者：
Morris, Elizabeth
中科院分区：
文献类型：
--
作者：
Narayan, Anand;Lebron-Zapata, Lizza;Morris, Elizabeth
变性患者经常接受跨性别荷尔蒙治疗，这使他们面临患乳腺癌的不确定风险。关于变性人患者接受乳房X光检查的程度，基于人群的信息有限。我们的目的是使用具有全国代表性的调查数据来确定变性人患者接受乳房X光检查的程度。2014年行为风险因素监测系统调查中年龄在40岁至74岁之间的变性人参与者包括在内。过去一年或两年接受乳房X光检查的比例按年龄类别和过渡状态[男性到女性(MTF)，女性到男性(FtM)，不符合标准]分层计算。对于每个过渡状态，使用Logistic回归计算乳房X光摄影筛查的预测因素。220名变性人患者年龄在40-74岁之间(35%是MTF，51%是FtM，14%是不符合)。60.0%的人在最近一年内接受了钼靶检查(MTF-54.5%，FtM-64.3%，不合格-58.1%)。74.1%的人在最近两年内接受过筛查(MTF-70.1%，FtM-75.9%，不合格-77.4%)。对于所有变性人患者，收入类别(OR 1.16，0.82-1.64)、高等教育类别(OR 1.09，0.31-3.86)和医疗保险(OR 0.38，0.10-1.41)与增加对乳房X光检查的依从性无关。与非变性人患者相比，变性人患者接受乳房X光检查的可能性相当(调整后OR为0.97，0.58-1.62)。在我们的样本中，高比例的变性人调查受访者接受了乳房X光检查(过去一年内57.9-66.1%，最近两年内71.9-74.4%)，比例与非变性人调查受访者相当。
Transgender patients undergoing transitions often receive cross-sex hormonal therapies, placing them at uncertain risk for developing breast cancer. There is limited population-based information about the extent to which transgender patients undergo mammography screening. Our purpose was to determine the extent to which transgender patients undergo mammography screening using nationally representative survey data.Transgender participants between ages 40-74 in the 2014 Behavioral Risk Factor Surveillance System survey were included. Proportions undergoing mammography screening in the last year or two years were calculated stratified by age category and transition status [male to female(MtF), female to male(FtM), non-conforming]. For each transition status, predictors of mammography screening were calculated using logistic regression.220 transgender patients were within 40-74 years old(35% were MtF, 51% were FtM, 14% were non-conforming). 60.0% underwent mammography screening within the last year (MtF-54.5%, FtM-64.3%, non-conforming-58.1%). 74.1% underwent screening within the last two years(MtF-70.1%, FtM-75.9%, non-conforming-77.4%). For all transgender patients, income category (OR 1.16, 0.82-1.64), higher education category (OR 1.09, 0.31-3.86) and health insurance (OR 0.38, 0.10-1.41) were not associated with increased adherence to mammography screening. Transgender patients were comparably likely to undergo mammography screening compared with non-transgender patients (Adjusted OR 0.97, 0.58-1.62).High proportions of transgender survey respondents undergo mammography screening (57.9-66.1% within the last year, 71.9-74.4% within the last two years) in our sample, proportions comparable to non-transgender survey respondents.